Spots Global Cancer Trial Database for A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer
Official Title: A Multi-center, Single Arm Study of Enzalutamide in Patients With Progressive Metastatic Castration-Resistant Prostate Cancer Previously Treated With Abiraterone Acetate
Study ID: NCT02116582
Interventions
Study Description
Brief Summary: The objective of this study was to evaluate the efficacy and safety of enzalutamide treatment in patients with progressive metastatic castration-resistant prostate cancer previously treated with abiraterone acetate.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Site BE32001, Brussels, Flemish Brabant, Belgium
Site BE32004, Gent, , Belgium
Site BE32007, Hasselt, , Belgium
Site BE32003, Kortrijk, , Belgium
Site BE32002, Liege, , Belgium
Site FR33015, Angers cedex 02, , France
Site FR33009, Caen Cedex 05, , France
Site FR33010, Creteil cedex, , France
Site FR33014, Le Mans, , France
Site FR33013, Lyon Cedex 3, , France
Site FR33003, Marseille CEDEX 9, , France
Site FR33008, Nantes Saint Herblain Cedex, , France
Site FR33002, Nimes, , France
Site FR33001, Paris cedex 15, , France
Site FR33011, Paris, , France
Site FR33007, Rennes, , France
Site FR33005, Suresnes, , France
Site FR33012, Villejiuf, , France
Site DE49005, Nuertingen, Baden-Wuerttemberg, Germany
Site DE49015, Bergisch Gladbach, Northwest, Germany
Site DE49017, Duisburg, NRW, Germany
Site DE49014, Berlin, , Germany
Site DE49003, Berlin, , Germany
Site DE49009, Bonn, , Germany
Site DE49010, Dresden, , Germany
Site DE49016, Duesseldorf, , Germany
Site DE49004, Goettingen, , Germany
Site DE49001, Hamburg, , Germany
Site DE49008, Hamburg, , Germany
Site DE49007, Hannover, , Germany
Site DE49002, Heidelberg, , Germany
Site DE49012, Munster, , Germany
Site DE49006, Tubingen, , Germany
Site ES34004, Santiago de Compostela, A Coruna, Spain
Site ES34009, Badalona, , Spain
Site ES34011, Barcelona, , Spain
Site ES34006, Barcelona, , Spain
Site ES34008, Barcelona, , Spain
Site ES34001, Madrid, , Spain
Site ES34003, Madrid, , Spain
Site ES34002, Madrid, , Spain
Site ES34010, Madrid, , Spain
Site GB44001, Sutton, Surrey, United Kingdom
Site GB44004, Birmingham, , United Kingdom
Site GB44009, Brighton, , United Kingdom
Site GB44002, Glasgow, , United Kingdom
Site GB44007, London, , United Kingdom
Site GB44003, Northwood, Middlesex, , United Kingdom
Site GB44010, Plymouth, , United Kingdom
Site GB44006, Withington, , United Kingdom
Contact Details
Name: Medical Director
Affiliation: Astellas Pharma Europe B.V.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
